The DS Prime Taper EV dental implant system was recently launched on the implant market by Dentsply Sirona (York, PA, USA). Dental implant systems are undergoing rapid evolution, ultimately driven by their broad therapeutic indications. As manufacturers strive to keep up with the demands of a growing market, designs are changing faster than clinical evaluation. This means that the time needed to assess medium- and long-term clinical outcomes before designs change again cannot be met. Clinicians need to have a "real" analysis of the clinical performance of implants before using them. Therefore, reporting of results is necessary to avoid use in patients without proper practical checks even before the recommended 10- and 15-year follow-up periods.
The DS PrimeTaper implant has macro-design features that differ from its predecessor, the OsseoSpeed EV implant (AstraTech Implant System EV, Dentsply Implants, Mölndal, Sweden) with which they share a common surface and internal connection. Its macro-design has been modified through the introduction of variable thread forms and a more pronounced taper, ultimately making it more aggressive in terms of cutting ability. While its predecessor, the OsseoSpeed EV implant, has sufficient scientific support, this new system recently introduced on the market does not. All the scientific contributions that can be made will therefore be a first guide for the clinician who wishes to start using this dental implant system.
Study Type
OBSERVATIONAL
Enrollment
150
Surgical placement of a DS Prime Taper implant and its posterior prosthesis.
Clínica Dental esteve
Alicante, Alicante, Spain
RECRUITINGImplant Survival Rate
Time of survival of DS Prime Taper dental implant placed
Time frame: through study completion, an average of 1 year
Implant Success Rate
Radiological assessment of Marginal Bone Levels around DS Prime Taper implants in function
Time frame: through study completion, an average of 1 year
Biological and mechanical complications events
All type of complications that may occur during implant survival
Time frame: through study completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.